Evidence map›Paper›PMID 40199901›Full record

ArticleNature communications2025

Spatially resolved atlas of breast cancer uncovers intercellular machinery of venular niche governing lymphocyte extravasation.

Xin Wang, Zhanyu Wang, Qijun Liao, Pei Yuan, Junpu Mei, Yin Zhang, Chao Wu, Xiyu Kang, Sufei Zheng, Chenxuan Yang and 22 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Xin Wang *Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, P. R. China.ORCID http://orcid.org/0000-0003-1753-2786
Zhanyu Wang *Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, P. R. China.ORCID http://orcid.org/0000-0001-9187-6419
Qijun Liao *BGI Research, Shenzhen, 518083, P. R. China.ORCID http://orcid.org/0000-0001-7517-9867
Pei Yuan *Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, P. R. China.
Junpu Mei *BGI Research, Sanya, 572025, P. R. China.
Yin Zhang *BGI Research, Shenzhen, 518083, P. R. China.
Chao WuBGI Research, Shenzhen, 518083, P. R. China.
Xiyu KangDepartment of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, P. R. China.
Sufei ZhengDepartment of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, P. R. China.
Chenxuan YangDepartment of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, P. R. China.
Jiaxiang LiuDepartment of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, P. R. China.
Qingyao ShangDepartment of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, P. R. China.
Jiangtao LiDepartment of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, P. R. China.
Bingning WangDepartment of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, P. R. China.
Liangyu LiBGI Research, Shenzhen, 518083, P. R. China.
Hui LiuBGI Research, Shenzhen, 518083, P. R. China.
Weining HuBGI Research, Shenzhen, 518083, P. R. China.
Zhensheng DongBGI Research, Shenzhen, 518083, P. R. China.
Jie ZhaoBGI Research, Shenzhen, 518083, P. R. China.
Linying WangBGI Research, Shenzhen, 518083, P. R. China.
Tao LiuBGI Research, Shenzhen, 518083, P. R. China.
Yusheng DenState Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120, P. R. China.
Chengrui WangState Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120, P. R. China.
Lijuan HanState Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120, P. R. China.
Qianjun ChenState Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120, P. R. China.
Huanming YangBGI Research, Shenzhen, 518083, P. R. China.
Xun XuBGI Research, Shenzhen, 518083, P. R. China.ORCID http://orcid.org/0000-0002-5338-5173
Jie HeDepartment of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, P. R. China.ORCID http://orcid.org/0000-0002-0285-5403
Zhen YueBGI Research, Sanya, 572025, P. R. China. yuezhen@genomics.cn.ORCID http://orcid.org/0000-0001-6993-6067
Nan SunDepartment of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, P. R. China. sunnan@cicams.ac.cn.ORCID http://orcid.org/0000-0001-6812-9917
Xiaodong FangBGI Research, Sanya, 572025, P. R. China. fangxd@genomics.cn.ORCID http://orcid.org/0000-0001-7061-3337
Jianming YingState Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, P. R. China. jmying@cicams.ac.cn.ORCID http://orcid.org/0000-0002-7301-4118

Funding

Beijing Municipal Science and Technology Commission 2024-2-4025Chinese Academy of Medical Sciences (CAMS) 2021-1-I2M-012Chinese Academy of Medical Sciences (CAMS) 2021-I2M-1-014Chinese Academy of Medical Sciences (CAMS) 2023-I2M-CT-A-009Government of Guangdong Province 2017B030301011Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) 2023ZD0502202National Natural Science Foundation of China (National Science Foundation of China) 81700436National Natural Science Foundation of China (National Science Foundation of China) 82072097National Natural Science Foundation of China (National Science Foundation of China) 82172876National Natural Science Foundation of China (National Science Foundation of China) 82203688National Natural Science Foundation of China (National Science Foundation of China) 82373060Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation) JQ23032
6 · The paper itself

Abstract

Breast cancers present intricate microenvironments comprising heterotypic cellular interactions, yet a comprehensive spatial map remained to be established. Here, we employed the DNA nanoball-based genome-wide in situ sequencing (Stereo-seq) to visualize the geospatial architecture of 30 primary breast tumors and metastatic lymph nodes across different molecular subtypes. This unprecedented high-resolution atlas unveils the fine structure of the tumor vasculature, highlighting heterogeneity in phenotype, spatial distribution, and intercellular communication within both endothelial and perivascular cells. In particular, venular smooth muscle cells are identified as the primary source of CCL21/CCL19 within the microenvironment. In collaboration with ACKR1-positive endothelial cells, they create a chemokine-rich venular niche to synergistically promote lymphocyte extravasation into tumors. High venule density predicts increased immune infiltration and improved clinical outcomes. This study provides a detailed spatial landscape of human breast cancer, offering key insights into the venular regulation of tumor immune infiltration.

Indexed as

Breast NeoplasmsLymphocytesCell CommunicationChemokine CCL21Endothelial CellsFemaleHumansLymphocytes, Tumor-InfiltratingMyocytes, Smooth MuscleTumor MicroenvironmentVenulesCCL21 protein, humanChemokine CCL21

Identifiers

PMID40199901
PMCPMC11978809

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.